The prion hypothesis: From biological anomaly to basic regulatory mechanism

Nature Reviews Molecular Cell Biology

Volumn 11, Issue 12, 2010, Pages 823-833

  Tuite, Mick F ^a   Serio, Tricia R ^b  

^a UNIVERSITY OF KENT   (United Kingdom)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 2; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; ORNITHINE DECARBOXYLASE; PRION PROTEIN; PROTEIN TYROSINE KINASE; TRANSFER RNA; ZINC FINGER PROTEIN;

CELL FUNCTION; CELL METABOLISM; DISEASE TRANSMISSION; EPIGENETICS; FUNGAL PRION; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PHENOTYPE; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; REGULATORY MECHANISM; REVIEW; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

ANIMALS; CELL PHYSIOLOGICAL PHENOMENA; EPIGENESIS, GENETIC; FUNGI; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; PHENOTYPE; PRION DISEASES; PRIONS; SIGNAL TRANSDUCTION;

FUNGAL PRION; FUNGI; MAMMALIA; PRIONS (INFECTIVE AGENTS);

EID: 78649417132     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3007     Document Type: Review

References (158)

1. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982).
2. Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363-13383 (1998).
3. Griffith, J. S. Self-replication and scrapie. Nature 21 5, 1043-1044 (1967).
4. Wickner, R. B., Edskes, H. K., Shewmaker, F. & Nakayashiki, T. Prions of fungi: inherited structures and biological roles. Nature Rev. Microbiol. 5, 611-618 (2007).
5. Collinge, J. & Clarke, A. R. A general model of prion strains and their pathogenicity. Science 318, 930-936 (2007).
6. Nemecek, J., Nakayashiki, T. & Wickner, R. B. A prion of yeast metacaspase homolog (Mca1p) detected by a genetic screen. Proc. Natl Acad. Sci. USA 106, 1892-1896 (2009).
7. Wickner, R. B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566-569 (1994).
8. Michelitsch, M. D. & Weissman, J. S. A census of glutamine/ asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc. Natl Acad. Sci. USA 97, 11910-11915 (2000).
9. Alberti, S., Halfmann, R., King, O., Kapila, A. & Lindquist, S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137, 146-158 (2009).
10. Cox, B. Ψ, A cytoplasmic suppressor of super-suppression in yeast. Heredity 20, 505-521 (1965).
11. Culbertson, M. R., Charnas, L., Johnson, M. T. & Fink, G. R. Frameshifts and frameshift suppressors in Saccharomyces cerevisiae. Genetics 86, 745-764 (1977).
12. Patino, M. M., Liu, J. J., Glover, J. R. & Lindquist, S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273, 622-626 (1996).
13. +] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBo J. 15, 3127-3134 (1996).
14. Chen, B., Newnam, G. P. & Chernoff, Y. O. Prion species barrier between the closely related yeast proteins is detected despite coaggregation. Proc. Natl Acad. Sci. USA 104, 2791-2796 (2007).
15. Eaglestone, S. S., Cox, B. S. & Tuite, M. F. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J. 18, 1974-1981 (1999).
16. True, H. L., Berlin, I. & Lindquist, S. L. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature 431, 184-187 (2004).
17. True, H. L. & Lindquist, S. L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477-483 (2000).
18. Williams, I., Richardson, J., Starkey, A. & Stansfield, I. Genome-wide prediction of stop codon readthrough during translation in the yeast Saccharomyces cerevisiae. Nucleic Acids Res. 32, 6605-6616 (2004).
19. +] and nonstop mRNA decay affect phenotypic variation. Proc. Natl Acad. Sci. USA 102, 10244-10249 (2005).
20. Palanimurugan, R., Scheel, H., Hofmann, K. & Dohmen, R. J. Polyamines regulate their synthesis by inducing expression and blocking degradation of ODC antizyme. EMBO J. 23, 4857-4867 (2004).
21. +]. Nature Cell Biol. 10, 1069-1075 (2008).
22. Namy, O., Duchateau-Nguyen, G. & Rousset, J. P. Translational readthrough of the PDE2 stop codon modulates cAMP levels in Saccharomyces cerevisiae. Mol. Microbiol. 43, 641-652 (2002).
23. Du, Z., Park, K. W., Yu, H., Fan, Q. & Li, L. Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nature Genet. 40, 460-465 (2008).
24. Patel, B. K., Gavin-Smyth, J. & Liebman, S. W. The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nature Cell Biol. 11, 344-349 (2009).
25. Hongay, C., Jia, N., Bard, M. & Winston, F. Mot3 is a transcriptional repressor of ergosterol biosynthetic genes and is required for normal vacuolar function in Saccharomyces cerevisiae. EMBO J. 21, 4114-4124 (2002).
26. Lempiäinen, H. & Shore, D. Growth control and ribosome biogenesis. Curr. opin. Cell Biol. 21, 855-863 (2009).
27. Courchesne, W. E. & Magasanik, B. Regulation of nitrogen assimilation in Saccharomyces cerevisiae: roles of the URE2 and GLN3 genes. J. Bacteriol. 170, 708-713 (1988).
28. Cunningham, T. S., Andhare, R. & Cooper, T. G. Nitrogen catabolite repression of DAL80 expression depends on the relative levels of Gat1p and Ure2p production in Saccharomyces cerevisiae. J. Biol. Chem. 275, 14408-14414 (2000).
29. Rai, R., Tate, J. J. & Cooper, T. G. Ure2, A prion precursor with homology to glutathione S-transferase, Protects Saccharomyces cerevisiae cells from heavy metal ion and oxidant toxicity. J. Biol. Chem. 278, 12826-12833 (2003).
30. +] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1. Proc. Natl Acad. Sci. USA 107, 10573-10577 (2010).
31. Saupe, S. J. A short history of small s: a prion of the fungus Podospora anserina. Prion 1, 110-115 (2007).
32. Coustou, V., Deleu, C., Saupe, S. & Begueret, J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl Acad. Sci. USA 94, 9773-9778 (1997).
33. Paoletti, M. & Saupe, S. J. Fungal incompatibility: evolutionary origin in pathogen defense? Bioessays 31, 1201-1210 (2009).
34. Greenwald, J. et al. The mechanism of prion inhibition by HET-S. Mol. Cell 38, 889-899 (2010).
35. Sondheimer, N. & Lindquist, S. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5, 163-172 (2000).
36. +]. Cell 106, 171-182 (2001).
37. +] prion. Cell 106, 183-194 (2001).
38. Resende, C. G., Outeiro, T. F., Sands, L., Lindquist, S. & Tuite, M. F. Prion protein gene polymorphisms in Saccharomyces cerevisiae. Mol. Microbiol. 49, 1005-1017 (2003).
39. +] are diseases. Proc. Natl Acad. Sci. USA 102, 10575-10580 (2005).
40. +] prion in yeast and aggregation of Sup35 in vitro. Proc. Natl Acad. Sci. USA 101, 12934-12939 (2004).
41. +]: a two-prion system in yeast? EMBO J. 19, 1942-1952 (2000).
42. Dalstra, H. J., Swart, K., Debets, A. J., Saupe, S. J. & Hoekstra, R. F. Sexual transmission of the [Het-S] prion leads to meiotic drive in Podospora anserina. Proc. Natl Acad. Sci. USA 100, 6616-6621 (2003).
43. Ter-Avanesyan, M. D. et al. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol. Microbiol. 7, 683-692 (1993).
44. Griswold, C. K. & Masel, J. Complex adaptations can drive the evolution of the capacitor [PSI], Even with realistic rates of yeast sex. PLoS Genet. 5, E1000517 (2009).
45. +] prion on rates of adaptation in yeast. J. Evol. Biol. 21, 773-780 (2008).
46. Brundin, P., Melki, R. & Kopito, R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature Rev. Mol. Cell Biol. 11, 301-307 (2010).
47. Meyer-Luehmann, M. et al. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313, 1781-1784 (2006).
48. Ren, P. H. et al. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nature Cell Biol. 11, 219-225 (2009).
49. Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Med. 14, 501-503 (2008).
50. Aguzzi, A. Cell biology: Beyond the prion principle. Nature 459, 924-925 (2009).
51. Glabe, C. G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 27, 570-575 (2006).
52. Barnhart, M. M. & Chapman, M. R. Curli biogenesis and function. Annu. Rev. Microbiol. 60, 131-147 (2006).
53. Si, K., Choi, Y. B., White-Grindley, E., Majumdar, A. & Kandel, E. R. Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 140, 421-435 (2010).
54. Fowler, D. M. et al. Functional amyloid formation within mammalian tissue. PLoS Biol. 4, E6 (2006).
55. Berson, J. F. et al. Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J. Cell Biol. 161, 521-533 (2003).
56. Maji, S. K. et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328-332 (2009).
57. Aguzzi, A., Baumann, F. & Bremer, J. The prion's elusive reason for being. Annu. Rev. Neurosci. 31, 439-477 (2008).
58. Mallucci, G. R. et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53, 325-335 (2007).
59. White, M. D. et al. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc. Natl Acad. Sci. USA 105, 10238-10243 (2008).
60. Steele, A. D., Lindquist, S. & Aguzzi, A. The prion protein knockout mouse: a phenotype under challenge. Prion 1, 83-93 (2007).
61. Isaacs, J. D., Jackson, G. S. & Altmann, D. M. The role of the cellular prion protein in the immune system. Clin. Exp. Immunol. 146, 1-8 (2006).
62. Wilson, D. A. & Nixon, R. A. Sniffing out a function for prion proteins. Nature Neurosci. 12, 7-8 (2009).
63. Malaga-Trillo, E. et al. Regulation of embryonic cell adhesion by the prion protein. PLoS Biol. 7, E55 (2009).
64. Bremer, J. et al. Axonal prion protein is required for peripheral myelin maintenance. Nature Neurosci. 13, 310-318 (2010).
65. C): its physiological function and role in disease. Biochim. Biophys. Acta 1772, 629-644 (2007).
66. Shmerling, D. et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203-214 (1998).
67. Baumann, F. et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 26, 538-547 (2007).
68. Mallucci, G. et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874 (2003).
69. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996).
70. Chesebro, B. et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439 (2005).
71. Nicoll, A. J. & Collinge, J. Preventing prion pathogenicity by targeting the cellular prion protein. Infect. Disord. Drug Targets 9, 48-57 (2009).
72. C in mediating the neurotoxic effect of scrapie prions in neurons. Curr. Issues Mol. Biol. 12, 119-128 (2009).
73. Sc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19-30 (1994).
74. Masel, J., Jansen, V. A. & Nowak, M. A. Quantifying the kinetic parameters of prion replication. Biophys. Chem. 77, 139-152 (1999).
75. Haslberger, T., Bukau, B. & Mogk, A. Towards a unifying mechanism for ClpB/Hsp104-mediated protein disaggregation and prion propagation. Biochem. Cell Biol. 88, 63-75 (2010).
76. Jones, G. W. & Tuite, M. F. Chaperoning prions: the cellular machinery for propagating an infectious protein? Bioessays 27, 823-832 (2005).
77. Prusiner, S. et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-686 (1990).
78. Manson, J. C., Clarke, A. R., McBride, P. A., McConnell, I. & Hope, J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3, 331-340 (1994).
79. Laurent, M. Bistability and the species barrier in prion diseases: stepping across the threshold or not. Biophys. Chem. 72, 211-222 (1998).
80. Sindi, S. S. & Serio, T. R. Prion dynamics and the quest for the genetic determinant in protein-only inheritance. Curr. opin. Microbiol. 12, 623-630 (2009).
81. Legname, G. et al. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl Acad. Sci. USA 103, 19105-19110 (2006).
82. Tanaka, M., Collins, S. R., Toyama, B. H. & Weissman, J. S. The physical basis of how prion conformations determine strain phenotypes. Nature 442, 585-589 (2006).
83. Kimberlin, R. H. & Walker, C. A. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J. Gen. Virol. 39, 487-496 (1978).
84. Marsh, R. F. & Hanson, R. P. in Slow Transmissible Diseases of the Nervous System (eds Prusiner, S. B. & Hadlow, W. J.) 451-460 (Academy Press, New York, 1979).
85. Dickinson, A. G. in Slow Virus Diseases of Animals and Man (ed. Kimberlin, R. H.) 209-241 (North-Holland Publishing Company, Amsterdam, 1976).
86. +] prion in yeast. Curr. Genet. 35, 59-67 (1999).
87. Ghaemmaghami, S. et al. Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog. 5, E1000673 (2009). Quinacrine treatment induces the loss of some prion strains while promoting the amplification of others.
88. Manuelidis, L., Fritch, W. & Xi, Y. G. Evolution of a strain of CJD that induces BSE-like plaques. Science 277, 94-98 (1997).
89. Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M. & Weissmann, C. Darwinian evolution of prions in cell culture. Science 327, 869-872 (2010).
90. Bruce, M. E. Scrapie strain variation and mutation. Br. Med. Bull. 49, 822-838 (1993).
91. Angers, R. C. et al. Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 328, 1154-1158 (2010).
92. Bessen, R. A. & Marsh, R. F. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J. Gen. Virol. 73, 329-334 (1992).
93. Dickinson, A. G. & Outram, G. W. in Virus Nonconventionnels et Affections du Systeme Nerveux Central (eds Court, L. A. & Cathala, F. ) 3-16 (Masson, Paris, 1983).
94. Sc types: an updated classification. Acta Neuropathol. 1 1 8, 659-671 (2009).
95. Cali, I. et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132, 2643-2658 (2009).
96. Bruce, M., Fraser, H., McBride, P., Scott, J. & Dickinson, A. in Prion Diseases of Humans and Animals (eds Prusiner, S., Collinge, J., Powell, J. & Anderton, B.) 497-508 (Ellis Horwood, New York, 1992).
97. Bartz, J. C., Bessen, R. A., McKenzie, D., Marsh, R. F. & Aiken, J. M. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J. Virol. 74, 5542-5547 (2000).
98. Dickinson, A. G. et al. Extraneural competition between different scrapie agents leading to loss of infectivity. Nature 253, 556 (1975).
99. Dickinson, A. G., Fraser, H., Meikle, V. M. & Outram, G. W. Competition between different scrapie agents in mice. Nature New Biol. 237, 244-245 (1972).
100. Dickinson, A. G. & Outram, G. W. in Slow Transmissible Diseases of The Nervous System (eds Prusiner, S. B. & Hadlow, W. J.) 13-31 (Academic Press, New York, 1979).
101. Shikiya, R. A., Ayers, J. I., Schutt, C. R., Kincaid, A. E. & Bartz, J. C. Coinfecting prion strains compete for a limiting cellular resource. J. Virol. 84, 5706-5714 (2010).
102. Bradley, M. E., Edskes, H. K., Hong, J. Y., Wickner, R. B. & Liebman, S. W. Interactions among prions and prion "strains" in yeast. Proc. Natl Acad. Sci. USA 99 (Suppl. 4), 16392-16399 (2002).
103. Morales, R., Abid, K. & Soto, C. The prion strain phenomenon: molecular basis and unprecedented features. Biochim. Biophys. Acta 1772, 681-691 (2007).
104. Goldfarb, L. et al. Patients wth Creutzfeldt-Jakob disease and kuru lack the mutation in the PRIP gene found in Gerstmann-Sträussler syndrome, But they show a different double-allele mutation in the same gene. Am. J. Hum. Genet. 45, A189 (1989).
105. Owen, F., Poulter, M., Collinge, J. & Crow, T. J. Codon 129 changes in the prion protein gene in Caucasians. Am. J. Hum. Genet. 46, 1215-1216 (1990).
106. Liemann, S. & Glockshuber, R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38, 3258-3267 (1999).
107. C. J. Biol. Chem. 279, 28515-28521 (2004).
108. Apetri, A. C., Vanik, D. L. & Surewicz, W. K. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Biochemistry 44, 15880-15888 (2005).
109. Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B. & Cohen, F. E. Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 277, 21140-21148 (2002).
110. Come, J. & Lansbury, P. Predisposition of prion protein homozygotes to Creutzfeldt-Jakob disease can be explained by a nucleation-dependent polymerization mechanism. J. Am. Chem. Soc. 1 1 6, 410 9-4110 (1994).
111. Tahiri-Alaoui, A., Gill, A. C., Disterer, P. & James, W. Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease. J. Biol. Chem. 279, 31390-31397 (2004).
112. Tahiri-Alaoui, A., Sim, V. L., Caughey, B. & James, W. Molecular heterosis of prion protein β-oligomers. A potential mechanism of human resistance to disease. J. Biol. Chem. 281, 34171-34178 (2006).
113. Jeong, B. H. et al. Association of sporadic Creutzfeldt-Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population. Neurogenetics 6, 229-232 (2005).
114. Westaway, D. et al. Distinct prion proteins in short and long scrapie incubation period mice. Cell 51, 651-662 (1987).
115. Dickinson, A. G., Meikle, V. M. & Fraser, H. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J. Comp. Pathol. 78, 293-299 (1968).
116. Foster, J. D. & Dickinson, A. G. The unusual properties of CH1641, A sheep-passaged isolate of scrapie. Vet. Rec. 123, 5-8 (1988).
117. Goldmann, W., Hunter, N., Smith, G., Foster, J. & Hope, J. PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, A natural host of scrapie. J. Gen. Virol. 75, 989-995 (1994).
118. Gordon, W. ARS91-53: Report of Scrapie Seminar, 53-68 (US Department of Agriculture, 1964).
119. Shibuya, S., Higuchi, J., Shin, R. W., Tateishi, J. & Kitamoto, T. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 43, 826-828 (1998).
120. Westaway, D. et al. Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev. 8, 959-969 (1994).
121. Kaneko, K. et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl Acad. Sci. USA 94, 10069-10074 (1997).
122. Perrier, V. et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl Acad. Sci. USA 99, 13079-13084 (2002).
123. Geoghegan, J. C,. Miller, M. B,. Kwak, A. H,. Harris, B. T. & Supattapone, S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog. 5, E1000535 (2009).
124. Lee, C. I., Yang, Q., Perrier, V. & Baskakov, I. V. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. Protein Sci. 16, 2166-2173 (2007).
125. Masel, J. & Jansen, V. A. Designing drugs to stop the formation of prion aggregates and other amyloids. Biophys. Chem. 88, 247-259 (2000).
126. DePace, A. H., Santoso, A., Hillner, P. & Weissman, J. S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93, 1241-1252 (1998).
127. Young, C. & Cox, B. Extrachromosomal elements in a super-suppression system of yeast I. A nuclear gene controlling the inheritance of the extrachromosomal elements. Heredity 26, 413-422 (1971).
128. - mutation which eliminates the Ψ factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137, 659-670 (1994).
129. King, C. Y. Supporting the structural basis of prion strains: induction and identification of [PSI] variants. J. Mol. Biol. 307, 1247-1260 (2001).
130. +prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. EMBO J. 17, 5805-5810 (1998).
131. Osherovich, L. Z., Cox, B. S., Tuite, M. F. & Weissman, J. S. Dissection and design of yeast prions. PLoS Biol. 2, E86 (2004).
132. Zlotnik, I. & Rennie, J. C. Experimental transmission of mouse passaged scrapie to goats, Sheep, Rats and hamsters. J. Comp. Pathol. 75, 147-157 (1965).
133. Pattison, I. in NINDB Monograph, No.2: Slow, Latent, And Temperate Virus Infections (eds Gajdusek D. C., Gibbs C. J. Jr & Alpers M. P.) 249-257 (US National Institutes of Health, Bethesda, Maryland, 1965).
134. Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690 (1996).
135. Bruce, M. E. et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501 (1997).
136. Marsh, R. F., Burger, D., Eckroade, R., Zu Rhein, G. M. & Hanson, R. P. A preliminary report on the experimental host range of the transmissible mink encephalopathy agent. J. Infect. Dis. 120, 713-719 (1969).
137. Hill, A. F. et al. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 97, 10248-10253 (2000).
138. Race, R. & Chesebro, B. Scrapie infectivity found in resistant species. Nature 392, 770 (1998).
139. Dickinson, A. G., Fraser, H. & Outram, G. W. Scrapie incubation time can exceed natural lifespan. Nature 256, 732-733 (1975).
140. Windl, O. et al. Breaking an absolute species barrier: transgenic mice expressing the mink PrP gene are susceptible to transmissible mink encephalopathy. J. Virol. 79, 14971-14975 (2005).
141. Sigurdson, C. J. et al. A molecular switch controls interspecies prion disease transmission in mice. J. Clin. Invest. 120, 2590-2599 (2010).
142. Chien, P., Weissman, J. S. & DePace, A. H. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 73, 617-656 (2004).
143. Sawaya, M. R. et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 447, 453-457 (2007).
144. Vanik, D. L., Surewicz, K. A. & Surewicz, W. K. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol. Cell 14, 139-145 (2004).
145. +] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mol. Cell 7, 1121-1130 (2001).
146. Chen, B. et al. Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol. Microbiol. 76, 1483-1499 (2010).
147. Edskes, H. K., McCann, L. M., Hebert, A. M. & Wickner, R. B. Prion variants and species barriers among Saccharomyces Ure2 proteins. Genetics 181, 1159-1167 (2009).
148. Kadnar, M. L., Articov, G. & Derkatch, I. L. Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1. PLoS Genet. 6, E1000824 (2010).
149. Jones, E. M. & Surewicz, W. K. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121, 63-72 (2005).
150. +]. Nature Struct. Mol. Biol. 16, 598-605 (2009).
151. Pattison, I. H. & Jones, K. M. Modification of a strain of mouse-adapted scrapie by passage through rats. Res. Vet. Sci. 9, 408-410 (1968).
152. Kimberlin, R. H., Walker, C. A. & Fraser, H. The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J. Gen. Virol. 70, 2017-2025 (1989).
153. Kimberlin, R. H., Cole, S. & Walker, C. A. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J. Gen. Virol. 68, 1875-1881 (1987).
154. Makarava, N., Ostapchenko, V. G., Savtchenko, R. & Baskakov, I. V. Conformational switching within individual amyloid fibrils. J. Biol. Chem. 284, 14386-14395 (2009).
155. Si, K., Lindquist, S. & Kandel, E. R. A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 1 1 5, 879-891 (2003).
156. Bernardi, G. Lessons from a small, Dispensable genome: the mitochondrial genome of yeast. Gene 354, 189-200 (2005).
157. Ross, E. D., Edskes, H. K., Terry, M. J. & Wickner, R. B. Primary sequence independence for prion formation. Proc. Natl Acad. Sci. USA 102, 12825-12830 (2005).
158. Taneja, V., Maddelein, M. L., Talarek, N., Saupe, S. J. & Liebman, S. W. A non-Q/N-rich prion domain of a foreign prion, [Het-s], Can propagate as a prion in yeast. Mol. Cell 27, 67-77 (2007).